✉news HealthMedicine first seen 9 h ago, last 27 min ago, peak #1

Single CRISPR treatment halves bad cholesterol for a year

Original: One CRISPR treatment cut “bad” cholesterol in half for a full year

A one-time CRISPR-based treatment has reportedly cut LDL, the so-called bad cholesterol, roughly in half with the effect lasting a full year, according to a report carried by ScienceDaily. If confirmed in larger trials, a single infusion could replace daily statins for some patients at risk of heart disease. The finding is drawing attention as a potential milestone for gene-editing therapies targeting common chronic conditions.

Why now: A one-time gene-editing therapy showing a year-long cholesterol reduction is a striking step toward lasting alternatives to daily medication.

CRISPRScienceDailyLDL cholesterol

Open on news →

Rank over time, top of the chart is #1. 13 snapshots from 9 h ago to 27 min ago.

Evidence

• One CRISPR treatment cut “bad” cholesterol in half for a full year · sciencedaily.com
• One CRISPR treatment cut “bad” cholesterol in half for a full year · ScienceDaily

API: https://socialmediatrends-api.osmike.com/v1/trends/115633